Ras-ERK1/2 Signaling Promotes the Development of Osteosarcoma by Regulating H2BK12ac Through CBP [Expression of Concern]
Authors Xu X, Yu H, Xu Y
Received 3 April 2020
Accepted for publication 3 April 2020
Published 8 April 2020 Volume 2020:12 Pages 2501—2502
Xu X, Yu H, Xu Y. Cancer Manag Res. 2019;11:9153–9163.
The Editor-in-Chief and Publisher of Cancer Management and Research wish to issue an Expression of Concern for the published article.
After publication of article, Ras-ERK1/2 Signaling Promotes The Development Of Osteosarcoma By Regulating H2BK12ac Through CBP; Xu X, Yu H, Xu Y. Cancer Management and Research 2019;11:9153–9163, questions about the scientific integrity of the article content were brought to the Publisher and Editor’s attention. We have reached out to the authors requesting that they supply
information that would confirm the article’s integrity, but the authors have not responded to our queries within the requested timeframe. Therefore, as we continue to work through the issues raised, we advise readers to interpret the information presented in the article with due caution.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]